JPS62223125A - 経口解毒剤 - Google Patents
経口解毒剤Info
- Publication number
- JPS62223125A JPS62223125A JP62012799A JP1279987A JPS62223125A JP S62223125 A JPS62223125 A JP S62223125A JP 62012799 A JP62012799 A JP 62012799A JP 1279987 A JP1279987 A JP 1279987A JP S62223125 A JPS62223125 A JP S62223125A
- Authority
- JP
- Japan
- Prior art keywords
- activated carbon
- spherical
- spherical activated
- diameter
- surface area
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000729 antidote Substances 0.000 title claims abstract description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 190
- 239000011148 porous material Substances 0.000 claims abstract description 17
- 239000002245 particle Substances 0.000 claims abstract description 10
- 230000000694 effects Effects 0.000 abstract description 24
- 239000007864 aqueous solution Substances 0.000 abstract description 11
- 206010010774 Constipation Diseases 0.000 abstract description 10
- 230000003213 activating effect Effects 0.000 abstract description 2
- 230000002605 anti-dotal effect Effects 0.000 abstract 1
- 238000010000 carbonizing Methods 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 16
- 238000000034 method Methods 0.000 description 15
- 239000000523 sample Substances 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 9
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 8
- 230000004913 activation Effects 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 238000001784 detoxification Methods 0.000 description 7
- 238000001179 sorption measurement Methods 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000011295 pitch Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 229910021529 ammonia Inorganic materials 0.000 description 5
- 239000003610 charcoal Substances 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 229940109239 creatinine Drugs 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 3
- 238000011047 acute toxicity test Methods 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 210000002249 digestive system Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 230000008991 intestinal motility Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000007873 sieving Methods 0.000 description 3
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003245 coal Substances 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229940105082 medicinal charcoal Drugs 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 230000006371 metabolic abnormality Effects 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- -1 pitch Chemical class 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000013094 purity test Methods 0.000 description 2
- 239000012798 spherical particle Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004526 pharmaceutical effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Carbon And Carbon Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62012799A JPS62223125A (ja) | 1979-06-26 | 1987-01-22 | 経口解毒剤 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8053779A JPS565313A (en) | 1979-06-26 | 1979-06-26 | Detoxificating spherical active carbon and preparing the same |
| JP62012799A JPS62223125A (ja) | 1979-06-26 | 1987-01-22 | 経口解毒剤 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8053779A Division JPS565313A (en) | 1977-12-27 | 1979-06-26 | Detoxificating spherical active carbon and preparing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62223125A true JPS62223125A (ja) | 1987-10-01 |
| JPS6360009B2 JPS6360009B2 (ru) | 1988-11-22 |
Family
ID=26348471
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62012799A Granted JPS62223125A (ja) | 1979-06-26 | 1987-01-22 | 経口解毒剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS62223125A (ru) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10316578A (ja) * | 1997-05-13 | 1998-12-02 | Kureha Chem Ind Co Ltd | リポタンパク質リパーゼ低血症改善剤 |
| JPH1129485A (ja) * | 1997-07-10 | 1999-02-02 | Kureha Chem Ind Co Ltd | 抗肥満剤 |
| JP2002308785A (ja) * | 2001-04-11 | 2002-10-23 | Kureha Chem Ind Co Ltd | 経口投与用吸着剤 |
| EP1748031A1 (en) * | 2004-04-02 | 2007-01-31 | Kureha Corporation | Method for producing spherical activated carbon |
| WO2010018855A1 (ja) * | 2008-08-14 | 2010-02-18 | ソニー株式会社 | 薬剤徐放剤、吸着剤、機能性食品、マスク及び吸着シート |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI370012B (en) * | 2004-04-02 | 2012-08-11 | Kureha Corp | Adsorbent for oral administration, and agent for treating or preventing renal or liver disease |
| WO2013051680A1 (ja) | 2011-10-07 | 2013-04-11 | 帝人ファーマ株式会社 | 経口投与用吸着剤 |
-
1987
- 1987-01-22 JP JP62012799A patent/JPS62223125A/ja active Granted
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10316578A (ja) * | 1997-05-13 | 1998-12-02 | Kureha Chem Ind Co Ltd | リポタンパク質リパーゼ低血症改善剤 |
| JPH1129485A (ja) * | 1997-07-10 | 1999-02-02 | Kureha Chem Ind Co Ltd | 抗肥満剤 |
| JP2002308785A (ja) * | 2001-04-11 | 2002-10-23 | Kureha Chem Ind Co Ltd | 経口投与用吸着剤 |
| EP1748031A1 (en) * | 2004-04-02 | 2007-01-31 | Kureha Corporation | Method for producing spherical activated carbon |
| EP1748031A4 (en) * | 2004-04-02 | 2011-03-09 | Kureha Corp | METHOD FOR PRODUCING SPHERICAL ACTIVE CHARCOAL |
| WO2010018855A1 (ja) * | 2008-08-14 | 2010-02-18 | ソニー株式会社 | 薬剤徐放剤、吸着剤、機能性食品、マスク及び吸着シート |
| JP2010106007A (ja) * | 2008-08-14 | 2010-05-13 | Sony Corp | 薬剤徐放剤、吸着剤、機能性食品、マスク及び吸着シート |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6360009B2 (ru) | 1988-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS6229368B2 (ru) | ||
| US4822765A (en) | Process for treating activated carbon with aqueous ammonia | |
| CA1112172A (en) | Antidote consisting of particles of activated carbon | |
| JP5124094B2 (ja) | 医薬用吸着剤 | |
| TWI319985B (en) | Adsorbent for oral administration, agent for treating or preventing renal disease, and agent for treating or preventing liver disease | |
| TWI625122B (zh) | 經口投與用吸附劑 | |
| JPS6211611B2 (ru) | ||
| KR100335023B1 (ko) | 염증성장질환치료용약제학적조성물 | |
| JP5984352B2 (ja) | 経口投与用医薬用吸着剤の製造方法 | |
| JP3518878B2 (ja) | 抗ネフローゼ症候群剤 | |
| JP5352378B2 (ja) | 吸着特性に優れた経口投与用吸着剤 | |
| JPS62223125A (ja) | 経口解毒剤 | |
| WO2014129618A1 (ja) | 経口投与用吸着剤並びに腎疾患治療剤及び肝疾患治療剤 | |
| JPH1129485A (ja) | 抗肥満剤 | |
| CN1117847A (zh) | 治疗痔疾病的药用组合物 | |
| WO2010001485A1 (ja) | 経口投与用吸着剤 | |
| JP6637573B2 (ja) | 吸着剤の製造方法 | |
| JP6431475B2 (ja) | 経口投与用吸着剤並びに腎疾患治療剤及び肝疾患治療剤 | |
| US20170252370A1 (en) | Adsorbent for oral administration, agent for treating renal disease, and agent for treating liver disease | |
| JPH0422618B2 (ru) | ||
| JP5985027B2 (ja) | 経口投与用医薬用吸着剤の製造方法 | |
| JP4875840B2 (ja) | 経口投与用活性炭製剤 | |
| Alkhatib et al. | The appropriate use of activated charcoal in pharmaceutical and toxicological approaches | |
| JP2799553B2 (ja) | 抗痔疾患剤 | |
| KR820000684B1 (ko) | 활성탄 입자로 된 해독제의 제조방법 |